Cipla Limited is a leading global pharmaceutical company dedicated to ensuring access to affordable, high-quality medicines across diverse therapeutic segments, including respiratory,
Cipla Ltd Q1 FY26 Earnings Results – 4% Revenue Growth, 10% Rise in Net Profit